Aliqopa Injection, Grade : Medicine Grade, Purity : 99% for Personal

FDA-Approved Indications Aliqopa is indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies. All other indications are considered experimental/investigational and not medically necessary.   Many injections are designed to administer a medication which has an effect throughout the body. Systemic injections may be used when a person cannot take medicine by mouth, or when the medication itself would not be absorbed into circulation from the gastrointestinal tract.